Elisa Oricchio (born 1979) is an Italian cancer researcher and associate professor at École Polytechnique Fédérale de Lausanne.

Oricchio moved to the United States almost immediately to begin her post-doctorate research at Memorial Sloan Kettering Cancer Center in New York City.

[4] In 2012, her research identified that nearly 70% of patients with follicular lymphoma have lost the EphA7 receptor[5] and she was experimenting with methods of reintroducing the protein into the cells.

[7] In 2013, she was awarded with a plaque from the town of Vallo della Lucania in her home region of Italy for her research,[2][8] which was successful in developing a mouse model.

[1] The Swiss Institute for Experimental Cancer Research created an endowed chair in Translational Oncology for Oricchio and effective 1 November 2014, she became a tenured assistant professor at the École Polytechnique Fédérale de Lausanne, School of Life Sciences.